European Society of Toxicology In Vitro > News > ESTIV and ONTOX signs Memorandum of Understanding
29 October 2021

ESTIV and ONTOX signs Memorandum of Understanding

Scope of Collaboration

ESTIV and ONTOX entered into the MoU to jointly conduct the following activities:

  • to share appropriate information related to the activities in the field of research on NAMs to adequate target audiences
  • to jointly organise events with clear mutual benefits for ESTIV and for ONTOX.

The MoU has been signed on 19 October 2021 by ESTIV President, Dr. Helena Kandarova and ONTOX Project Coordinator, Prof. Mathieu Vinken (VUB).


ONTOX is conducting a research project in the context of the European H2020 Research and Innovation Programme SC1-BHC-11-2020 called “Advancing the safety assessment of chemicals without the use of animal testing”. The vision of the ONTOX consortium is to provide a functional and sustainable solution for advancing human risk assessment of chemicals without the use of animals in line with the principles of 21st century toxicity testing and next generation risk assessment. More at: www.ontox-project.eu

Related content

ESTIV – ASCCT Award Winners Series: Hung-Lin Kan and Ricardo Scheufen Tieghi

Please join us on February 20, 2025, for the next installment of our 2025 Award Winners Webinar Series…

2025 JRC Summer School – 2 Travel bursaries up to 500 Euro each

  • News

Early-career scientists who intend to pursue a career in non-animal methods are invited to apply for an award for reimbursement …

Call for Proposals: ESTIV 2026 in Maastricht!

  • News

We want to remind all our members, followers and friends that session proposal submissions for the ESTIV2026 Congress in Maastricht are now open! 🎉

Silver Sponsor

Memorandum of Understanding